Literature DB >> 28317311

Novel pathogenic variants in FOXP3 in fetuses with echogenic bowel and skin desquamation identified by ultrasound.

Raymond J Louie1, Queenie K-G Tan2, Jennifer B Gilner2, R Curtis Rogers1, Noelle Younge2, Stephanie B Wechsler2, Marie T McDonald2, Barbara Gordon1, Christopher A Saski3, Julie R Jones1, Shelley J Chapman4, Roger E Stevenson1, John W Sleasman2, Michael J Friez1.   

Abstract

Immunodysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) syndrome is a rare, X-linked recessive disease that affects regulatory T cells (Tregs) resulting in diarrhea, enteropathy, eczema, and insulin-dependent diabetes mellitus. IPEX syndrome is caused by pathogenic alterations in FOXP3 located at Xp11.23. FOXP3 encodes a transcription factor that interacts with several partners, including NFAT and NF-κB, and is necessary for the proper cellular differentiation of Tregs. Although variable, the vast majority of IPEX syndrome patients have onset of disease during infancy with severe enteropathy. Only five families with prenatal presentation of IPEX syndrome have been reported. Here, we present two additional prenatal onset cases with novel inherited frameshift pathogenic variants in FOXP3 that generate premature stop codons. Ultrasound findings in the first patient identified echogenic bowel, echogenic debris, scalp edema, and hydrops. In the second patient, ultrasound findings included polyhydramnios with echogenic debris, prominent fluid-filled loops of bowel, and echogenic bowel. These cases further broaden the phenotypic spectrum of IPEX syndrome by describing previously unappreciated prenatal ultrasound findings associated with the disease.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  FOXP3; IPEX; X-linked; prenatal

Mesh:

Substances:

Year:  2017        PMID: 28317311      PMCID: PMC5515470          DOI: 10.1002/ajmg.a.38144

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  27 in total

1.  FOXP3 orchestrates H4K16 acetylation and H3K4 trimethylation for activation of multiple genes by recruiting MOF and causing displacement of PLU-1.

Authors:  Hiroto Katoh; Zhaohui S Qin; Runhua Liu; Lizhong Wang; Weiquan Li; Xiangzhi Li; Lipeng Wu; Zhanwen Du; Robert Lyons; Chang-Gong Liu; Xiuping Liu; Yali Dou; Pan Zheng; Yang Liu
Journal:  Mol Cell       Date:  2011-12-09       Impact factor: 17.970

Review 2.  Fetal-onset IPEX: report of two families and review of literature.

Authors:  Mariana Moraes Xavier-da-Silva; Carlos A Moreira-Filho; Edson Suzuki; Francy Patricio; Antonio Coutinho; Magda Carneiro-Sampaio
Journal:  Clin Immunol       Date:  2014-12-27       Impact factor: 3.969

3.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

Review 4.  Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.

Authors:  R S Wildin; S Smyk-Pearson; A H Filipovich
Journal:  J Med Genet       Date:  2002-08       Impact factor: 6.318

Review 5.  FOXP3 and scurfy: how it all began.

Authors:  Fred Ramsdell; Steven F Ziegler
Journal:  Nat Rev Immunol       Date:  2014-04-11       Impact factor: 53.106

6.  Wild-type FOXP3 is selectively active in CD4+CD25(hi) regulatory T cells of healthy female carriers of different FOXP3 mutations.

Authors:  Sara Di Nunzio; Massimiliano Cecconi; Laura Passerini; Alicia N McMurchy; Udo Baron; Ivana Turbachova; Silvia Vignola; Erica Valencic; Alberto Tommasini; Anne Junker; Giantonio Cazzola; Sven Olek; Megan K Levings; Lucia Perroni; Maria Grazia Roncarolo; Rosa Bacchetta
Journal:  Blood       Date:  2009-09-08       Impact factor: 22.113

Review 7.  The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.

Authors:  Eva d'Hennezel; Khalid Bin Dhuban; Troy Torgerson; Ciriaco A Piccirillo; Ciriaco Piccirillo
Journal:  J Med Genet       Date:  2012-05       Impact factor: 6.318

Review 8.  Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders: an evolving web of heritable autoimmune diseases.

Authors:  James W Verbsky; Talal A Chatila
Journal:  Curr Opin Pediatr       Date:  2013-12       Impact factor: 2.856

9.  Speech delays and behavioral problems are the predominant features in individuals with developmental delays and 16p11.2 microdeletions and microduplications.

Authors:  Jill A Rosenfeld; Justine Coppinger; Bassem A Bejjani; Santhosh Girirajan; Evan E Eichler; Lisa G Shaffer; Blake C Ballif
Journal:  J Neurodev Disord       Date:  2010-03       Impact factor: 4.025

10.  Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity.

Authors:  Federica Barzaghi; Laura Passerini; Rosa Bacchetta
Journal:  Front Immunol       Date:  2012-07-31       Impact factor: 7.561

View more
  15 in total

1.  MN1 C-terminal truncation syndrome is a novel neurodevelopmental and craniofacial disorder with partial rhombencephalosynapsis.

Authors:  Christopher C Y Mak; Dan Doherty; Angela E Lin; Nancy Vegas; Megan T Cho; Géraldine Viot; Clémantine Dimartino; James D Weisfeld-Adams; Davor Lessel; Shelagh Joss; Chumei Li; Claudia Gonzaga-Jauregui; Yuri A Zarate; Nadja Ehmke; Denise Horn; Caitlin Troyer; Sarina G Kant; Youngha Lee; Gisele E Ishak; Gordon Leung; Amanda Barone Pritchard; Sandra Yang; Eric G Bend; Francesca Filippini; Chelsea Roadhouse; Nicolas Lebrun; Michele G Mehaffey; Pierre-Marie Martin; Benjamin Apple; Francisca Millan; Oliver Puk; Mariette J V Hoffer; Lindsay B Henderson; Ruth McGowan; Ingrid M Wentzensen; Steven Pei; Farah R Zahir; Mullin Yu; William T Gibson; Ann Seman; Marcie Steeves; Jill R Murrell; Sabine Luettgen; Elizabeth Francisco; Tim M Strom; Louise Amlie-Wolf; Angela M Kaindl; William G Wilson; Sara Halbach; Lina Basel-Salmon; Noa Lev-El; Jonas Denecke; Lisenka E L M Vissers; Kelly Radtke; Jamel Chelly; Elaine Zackai; Jan M Friedman; Michael J Bamshad; Deborah A Nickerson; Russell R Reid; Koenraad Devriendt; Jong-Hee Chae; Elliot Stolerman; Carey McDougall; Zöe Powis; Thierry Bienvenu; Tiong Y Tan; Naama Orenstein; William B Dobyns; Joseph T Shieh; Murim Choi; Darrel Waggoner; Karen W Gripp; Michael J Parker; Joan Stoler; Stanislas Lyonnet; Valérie Cormier-Daire; David Viskochil; Trevor L Hoffman; Jeanne Amiel; Brian H Y Chung; Christopher T Gordon
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

2.  BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells.

Authors:  Davor Lessel; Christina Gehbauer; Nuria C Bramswig; Caroline Schluth-Bolard; Sathish Venkataramanappa; Koen L I van Gassen; Maja Hempel; Tobias B Haack; Anja Baresic; Casie A Genetti; Mariana F A Funari; Ivana Lessel; Leonie Kuhlmann; Ruth Simon; Pentao Liu; Jonas Denecke; Alma Kuechler; Ineke de Kruijff; Moneef Shoukier; Monkol Lek; Thomas Mullen; Hermann-Josef Lüdecke; Antonio M Lerario; Robin Kobbe; Thorsten Krieger; Benedicte Demeer; Marine Lebrun; Boris Keren; Caroline Nava; Julien Buratti; Alexandra Afenjar; Marwan Shinawi; Maria J Guillen Sacoto; Julie Gauthier; Fadi F Hamdan; Anne-Marie Laberge; Philippe M Campeau; Raymond J Louie; Sara S Cathey; Immo Prinz; Alexander A L Jorge; Paulien A Terhal; Boris Lenhard; Dagmar Wieczorek; Tim M Strom; Pankaj B Agrawal; Stefan Britsch; Eva Tolosa; Christian Kubisch
Journal:  Brain       Date:  2018-08-01       Impact factor: 13.501

3.  Key apoptotic genes APAF1 and CASP9 implicated in recurrent folate-resistant neural tube defects.

Authors:  Catherine J Spellicy; Joy Norris; Renee Bend; Caleb Bupp; Paul Mester; Tracy Reynolds; Jane Dean; Yunhui Peng; Emil Alexov; Charles E Schwartz; Roger S Stevenson; Michael J Friez
Journal:  Eur J Hum Genet       Date:  2018-01-22       Impact factor: 4.246

4.  A hemizygous mutation in the FOXP3 gene (IPEX syndrome) resulting in recurrent X-linked fetal hydrops: a case report.

Authors:  Panicos Shangaris; Alison Ho; Dharmintra Pasupathy; Muriel Holder-Espinasse; Andreas Marnerides; Simi George; Mudher AlAdnani; Shu Yau; Mattias Jansson; Jacqueline Hoyle; Joo Wook Ahn; Sian Ellard; Melita Irving; Diana Wellesley
Journal:  BMC Med Genomics       Date:  2021-02-26       Impact factor: 3.063

5.  Clinical findings and a DNA methylation signature in kindreds with alterations in ZNF711.

Authors:  Jiyong Wang; Aidin Foroutan; Ellen Richardson; Steven A Skinner; Jack Reilly; Jennifer Kerkhof; Cynthia J Curry; Patrick S Tarpey; Stephen P Robertson; Isabelle Maystadt; Boris Keren; Joanne W Dixon; Cindy Skinner; Rachel Stapleton; Lyse Ruaud; Evren Gumus; Phillis Lakeman; Mariëlle Alders; Matthew L Tedder; Charles E Schwartz; Michael J Friez; Bekim Sadikovic; Roger E Stevenson
Journal:  Eur J Hum Genet       Date:  2022-01-07       Impact factor: 4.246

6.  A Structure-Guided Delineation of FOXP3 Regulation Mechanism in IPEX.

Authors:  Tengyun Ma; Xiaomin Song; Ciriaco A Piccirillo; Guoping Deng; Mark I Greene
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  A delayed diagnosis of atypical immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: A case report.

Authors:  Ying Zhang; Hanmin Liu; Tao Ai; Wanmin Xia; Tingting Chen; Lei Zhang; Xiulan Luo; Yaping Duan
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

8.  CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language.

Authors:  Lot Snijders Blok; Justine Rousseau; Joanna Twist; Sophie Ehresmann; Motoki Takaku; Hanka Venselaar; Lance H Rodan; Catherine B Nowak; Jessica Douglas; Kathryn J Swoboda; Marcie A Steeves; Inderneel Sahai; Connie T R M Stumpel; Alexander P A Stegmann; Patricia Wheeler; Marcia Willing; Elise Fiala; Aaina Kochhar; William T Gibson; Ana S A Cohen; Ruky Agbahovbe; A Micheil Innes; P Y Billie Au; Julia Rankin; Ilse J Anderson; Steven A Skinner; Raymond J Louie; Hannah E Warren; Alexandra Afenjar; Boris Keren; Caroline Nava; Julien Buratti; Arnaud Isapof; Diana Rodriguez; Raymond Lewandowski; Jennifer Propst; Ton van Essen; Murim Choi; Sangmoon Lee; Jong H Chae; Susan Price; Rhonda E Schnur; Ganka Douglas; Ingrid M Wentzensen; Christiane Zweier; André Reis; Martin G Bialer; Christine Moore; Marije Koopmans; Eva H Brilstra; Glen R Monroe; Koen L I van Gassen; Ellen van Binsbergen; Ruth Newbury-Ecob; Lucy Bownass; Ingrid Bader; Johannes A Mayr; Saskia B Wortmann; Kathy J Jakielski; Edythe A Strand; Katja Kloth; Tatjana Bierhals; John D Roberts; Robert M Petrovich; Shinichi Machida; Hitoshi Kurumizaka; Stefan Lelieveld; Rolph Pfundt; Sandra Jansen; Pelagia Deriziotis; Laurence Faivre; Julien Thevenon; Mirna Assoum; Lawrence Shriberg; Tjitske Kleefstra; Han G Brunner; Paul A Wade; Simon E Fisher; Philippe M Campeau
Journal:  Nat Commun       Date:  2018-11-05       Impact factor: 14.919

9.  Human interleukin-2 receptor β mutations associated with defects in immunity and peripheral tolerance.

Authors:  Zinan Zhang; Florian Gothe; Perrine Pennamen; Sophie Hambleton; Caroline Rooryck; Kenneth G C Smith; Michael J Lenardo; John R James; David McDonald; Carlos P Mata; Yorgo Modis; Anas M Alazami; Meghan Acres; Wolfram Haller; Claire Bowen; Rainer Döffinger; Jan Sinclair; Shannon Brothers; Yu Zhang; Helen F Matthews; Sophie Naudion; Fanny Pelluard; Huda Alajlan; Yasuhiro Yamazaki; Luigi D Notarangelo; James E Thaventhiran; Karin R Engelhardt; Hamoud Al-Mousa
Journal:  J Exp Med       Date:  2019-04-30       Impact factor: 14.307

10.  Two unrelated patients with autosomal dominant omodysplasia and FRIZZLED2 mutations.

Authors:  Hannah E Warren; Raymond J Louie; Michael J Friez; Jaime L Frías; Jules G Leroy; Jürgen W Spranger; Steven A Skinner; Neena L Champaigne
Journal:  Clin Case Rep       Date:  2018-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.